Research programme: myocardial signal transducers - Millennium
Alternative Names: Myocardial signal transducers research programme - MillenniumLatest Information Update: 28 Jun 2006
At a glance
- Originator Millennium Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Myocardial ischaemia
Most Recent Events
- 21 Jun 2006 No development reported - Preclinical for Myocardial ischaemia in USA (unspecified route)
- 20 Jun 2006 No development reported - Preclinical for Congestive heart failure in USA (unspecified route)
- 21 Mar 2002 COR Therapeutics has been acquired by, and integrated into, Millennium Pharmaceuticals